 Recent advances etoposide therapy non-small cell lung cancer Non-small cell lung cancer NSCLC major health problem US new cases majority patients unresectable disease disease low chance variety chemotherapy treatments patients advanced NSCLC objective review results chemotherapy trials Stage III IV NSCLC patients